30 April 1999
HCV genotypes in children and young adults with chronic viral hepatitis C in self-selected material
Anna Szaflarska-Szczepanik, Mieczysława Czerwionka-Szaflarska, Andrzej ChrobotMed Sci Monit 1999; 5(3): CR514-518 :: ID: 504911
Abstract
Data concerning the occurrence of particular HCV types and subtypes in Poland are incomplete and refer mainly to adult patients. The aim of this work was to analyse HCV genotypes in children and young adults with chronic hepatitis. The study was conducted on 54 patients (27 boys and 27 girls) aged 3-20 years, suffering from chronic hepatitis C diagnosed on the basis of serological investigations (over 6-month presence of anti HCV-test UBI, LIATEK and HCV-RNA with the use of RT-PCR method) as well as histopathological evaluation of liver bioptates (according to modified Scheuer classification). HCV genotypes were investigated with the use of Line Probe Assay (INNO - Lipa HCV, Innogenetics) and systematised according to Simmonds classification. Analysis of the frequency of certain HCV genotypes revealed the presence of 1b subtype in 29 patients (53.7%), 1a subtype - in 9 (16.7%), 1 - in 1 (1.8%), 3a - in 3 (5.6%) and 4 - in 12 (22.2%) patients. Mean AlAT activity was 89.6 U/l in subjects with 1a genotype, 68 U/l - in those with 1b, 64 U/L - in patients with genotype 1.43 U/l - in patients with genotype 3a, and 78 U/l - in those with genotype 4. In histopathological picture, trace or slight lesions prevailed, while inflammatory activity of moderate intensification was observed in 14 patients (28%) with various HCV genotypes in a similar percentage of cases. No features of fibrosis were found in the majority of patients, irrespective of HCV type. Type 1 is a dominant genotype in the population of children and young adults with chronic hepatitis C, while clinical picture and the advancement of histopathological lesions in the liver are similar in patients with different genotypes.
Keywords: children and young adults, chronic hepatitis C, HCV genotype
379 0
Editorial
01 June 2023 : Editorial
Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic PreparednessDOI: 10.12659/MSM.941209
Med Sci Monit 2023; 29:e941209
In Press
08 Jun 2023 : Clinical Research
Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical Research
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical Research
Burden of COVID-19 on Mental Health of Resident Doctors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical Research
Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952